Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	98.68	91.15	192.43	360.38	194.61	88.04
Short-Term Investments	619.07	700.01	297.45	-	-	-
Cash & Short-Term Investments	717.75	791.15	489.88	360.38	194.61	88.04
Cash Growth	10.43%	61.50%	35.93%	85.18%	121.06%	1855.05%
Other Current Assets	15.02	12.75	3.73	5.28	3.88	2.45
Total Current Assets	732.76	803.9	493.62	365.66	198.49	90.48
Net Property, Plant & Equipment	1.81	1.91	2.67	2.1	1.6	1.75
Other Long-Term Assets	0.5	0.73	0.84	0.23	0.12	0.18
Total Assets	735.07	806.88	496.77	368	200.21	92.41
Accounts Payable	6.84	9.02	7.95	12.63	16.16	2.56
Accrued Expenses	23.21	27.01	15.24	8.15	6.11	4.1
Current Portion of Leases	0.32	0.61	0.13	0.67	0.31	0.32
Total Current Liabilities	30.36	36.64	23.32	21.44	22.58	6.97
Long-Term Debt	59.34	29.16	28.32	-	-	-
Long-Term Leases	1.21	1.25	1.55	1.44	1.03	1.33
Other Long-Term Liabilities	-	-	-	-	-	6.45
Total Long-Term Liabilities	60.55	30.41	29.87	1.44	1.03	7.78
Total Liabilities	90.91	67.05	53.19	22.88	23.61	14.76
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	1,279	1,249	741.3	533.76	288.81	1.19
Accumulated Other Comprehensive Income	-1.61	0.97	0.29	-	-	-
Retained Earnings	-633.22	-510.19	-298	-188.65	-112.22	-65.39
Total Common Shareholders' Equity	644.16	739.83	443.59	345.12	176.6	-64.2
Minority Interest	-	-	-	-	-	141.86
Shareholders' Equity	644.16	739.83	443.59	345.12	176.6	77.65
Total Liabilities & Equity	735.07	806.88	496.77	368	200.21	92.41
Total Debt	60.86	31.02	30	2.1	1.33	1.65
Net Cash (Debt)	656.88	760.13	459.88	358.28	193.28	86.38
Net Cash Growth	6.11%	65.29%	28.36%	85.37%	123.74%	-
Net Cash Per Share	17.52	21.54	16.66	16.05	185.93	98.34
Book Value	644.16	739.83	443.59	345.12	176.6	-64.2
Book Value Per Share	17.18	20.96	16.07	15.47	169.89	-73.09
Tangible Book Value	644.16	739.83	443.59	345.12	176.6	-64.2
Tangible Book Value Per Share	17.18	20.96	16.07	15.47	169.89	-73.09

SEC Filings: 10-K · 10-Q